HILOTHERAPY for hand-foot syndrome

Through this thermal procedure, tissue temperatures in the localized areas of the hands and feet are kept cool at a set, ­constant degree level.
The resulting decline in blood flow and metabolism, a reduction of tissue temperature by just 10°C already reduces the metabolic rate by 50% and reduces the amount of specific chemotherapeutic agents discharged via the sweat glands.
This helps prevent the onset of hand-foot syndrome. It also helps protect patients against any follow-up impact that could affect their hands and feet. These range from a tingling sensation, feeling of numbness, and highly painful redness in the extremities, up to swelling, open wounds, or even the loss of fingernails and toenails. In the worst case, even chemotherapy will then have to be interrupted or discontinued.

Application of Hilotherapy for hand-foot syndrome

How hand-foot syndrome develops

The syndrome refers to side effects that can occur in certain types of chemotherapy. Parts of the chemotherapeutic agent get directed to the surface of the skin via the sweat glands, where they come into contact with oxygen and form “free radicals.” These damage the tissue cells of the skin, especially where it’s especially thick in the horny skin layer and absorbs the substance like a sponge on the inner hands and the soles of the feet. The side affects manifest as tingling or numbness of the hands and feet and strongly painful and tender reddened areas, or can even extend to swelling, scaly skin, and open wounds.

HILOTHERM Chemocare
The therapeutic device for hand-foot syndrome

The device actuates a closed-loop system with conduits and cuffs, through which the cooling medium, water, flows at an adjustable temperature.
The anatomically formed hand and foot cuffs are equipped with delicate flow channels.

MORE INFORMATION ON HILOTHERM CHEMOCARE